{
    "fund_name": "iShares iBonds Dec 2026 Term $ CorpUSD (Acc)",
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [
        "Term structure complexity (fixed maturity date)",
        "ESG screening criteria may reduce investment universe",
        "Potential for credit downgrades affecting holdings"
    ],
    "classification": "non-complex",
    "supporting_data": "The ETF uses physical replication to track the Bloomberg MSCI December 2026 Maturity USD Corporate ESG Screened Index. While it holds corporate bonds with some credit risk and ESG screening, there is no leverage, inverse exposure, or synthetic replication. The term structure (fixed maturity in 2026) adds some complexity but does not meet MiFID II's criteria for a 'complex' financial instrument. The use of derivatives is limited to securities lending (for cost reduction), which is not a primary investment strategy. The risk profile is rated '3' (moderate) and aligns with the underlying bond holdings. No counterparty risk from swaps or derivatives is present beyond standard securities lending arrangements.",
    "confidence": 90,
    "counter_argument": "The term structure and ESG screening could be argued to add complexity, but these factors are common in fixed-income ETFs and do not meet MiFID II's threshold for complexity. The absence of derivatives beyond securities lending and the physical replication method confirm the non-complex classification.",
    "risk_level": "moderate"
}